Assessing Minimal Disease in Plasma Cell Neoplasms: A Comparison between Multicolor Flow Cytometry and Immunohistochemistry

被引：0
|
作者：
Ng, D. P.
Liang, C. S.
Tian, T.
Yin, C.
Young, K. H.
Jorgensen, J. L.
Hoehn, D.
Sargent, R.
Miranda, R. N.
Amin, H. M.
You, J.
Schlette, E.
Lin, P.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
来源：
LABORATORY INVESTIGATION | 2012年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1500
引用
收藏
页码：357A / 357A
页数：1
相关论文
共 50 条
  • [11] Diagnosis of Plasma Cell Dyscrasias and Monitoring of Minimal Residual Disease by Multiparametric Flow Cytometry
    Soh, Kah Teong
    Tario, Joseph D., Jr.
    Wallace, Paul K.
    CLINICS IN LABORATORY MEDICINE, 2017, 37 (04) : 821 - 853
  • [12] Selective Immunophenotyping for Diagnosis of B-cell Neoplasms: Immunohistochemistry and Flow Cytometry Strategies and Results
    Boyd, Scott D.
    Natkunam, Yasodha
    Allen, John R.
    Warnke, Roger A.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2013, 21 (02) : 116 - 131
  • [13] Comparative Analysis of Multicolor Flow Cytometry and Immunohistochemistry for the Detection of Disseminated Tumor Cells
    Szantho, Eszter
    Karai, Bettina
    Ivady, Gergely
    Bedekovics, Judit
    Szegedi, Istvan
    Petras, Miklos
    Ujj, Gyorgy
    Ujfalusi, Aniko
    Kiss, Csongor
    Kappelmayer, Janos
    Hevessy, Zsuzsanna
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2018, 26 (05) : 305 - 315
  • [14] CD45 Expression in Plasma Cell Myeloma: Comparison of Flow Cytometry and Immunohistochemistry and Relationship to Prognostic Factors
    Rathke, S. K.
    Olteanu, H.
    Kroft, S. H.
    Harrington, A. M.
    MODERN PATHOLOGY, 2011, 24 : 317A - 317A
  • [15] CD45 Expression in Plasma Cell Myeloma: Comparison of Flow Cytometry and Immunohistochemistry and Relationship to Prognostic Factors
    Rathke, S. K.
    Olteanu, H.
    Kroft, S. H.
    Harrington, A. M.
    LABORATORY INVESTIGATION, 2011, 91 : 317A - 317A
  • [16] Minimal residual disease (MRD) in hairy cell leukemia (HCL):: Comparative detection by flow cytometry (FC) and immunohistochemistry (IHC).
    Sarmiento, M
    Scolnik, M
    Narbaitz, M
    Bengió, R
    BLOOD, 1999, 94 (10) : 284A - 284A
  • [17] Quality Parameters for Flow Cytometric Minimal Residual Disease (MRD) Assessment in Plasma Cell Neoplasms
    Qureshi, Rashid
    Otteson, Gregory
    Timm, Michael
    Shi, Min
    Olteanu, Horatiu
    Kumar, Shaji
    Jevremovic, Dragan
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1367 - 1368
  • [18] Quality Parameters for Flow Cytometric Minimal Residual Disease (MRD) Assessment in Plasma Cell Neoplasms
    Qureshi, Rashid
    Otteson, Gregory
    Timm, Michael
    Shi, Min
    Olteanu, Horatiu
    Kumar, Shaji
    Jevremovic, Dragan
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1367 - 1368
  • [19] DNA CYTOMETRY IN THYMIC NEOPLASMS - A COMPARISON BETWEEN FLOW AND IMAGE CYTOMETRY AND CORRELATION WITH CLINICAL OUTCOME
    KENNYMOYNIHAN, MB
    GAL, AA
    KORNSTEIN, MJ
    DEROSE, PB
    COHEN, C
    LABORATORY INVESTIGATION, 1994, 70 (01) : A164 - A164
  • [20] A Limited Plasma Cell Flow Cytometry Panel With Reflex CD138 Immunohistochemistry Is an Optimal Workflow Process for Evaluating Plasma Cell Neoplasms in Bone Marrow Specimens
    Chen, Zhongchuan Will
    Perkins, Sherrie L.
    Weiss, Ronald L.
    Bahler, David W.
    Hussong, Jerry W.
    Salama, Mohamed E.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 143 (01) : 78 - 83
12345